Digoxin in Heart Failure: Kabhi Haan, Kabhi Naa


Dr Nagaraj Desai, Mysuru    06 January 2018

  1. There are no major studies to reassess the readmission rates, a major issue in current HF practice.
  2. It may be used in selected individuals only as add-on therapy albeit with well-known caveats like its narrow therapeutic window.
  3. A typical example may be a patient of systolic HF in AF with faster heart rate who is not responding adequately despite routine guideline directed therapies including RAAS modulators and b blockers.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.